Cite
HARVARD Citation
Skrivanek, Z. et al. (n.d.). Dose‐finding results in an adaptive, seamless, randomized trial of once‐weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD‐5). Diabetes, obesity & metabolism. 16 (8), pp. 748-756. [Online].